Design Therapeutics
DSGN
DSGN
52 hedge funds and large institutions have $415M invested in Design Therapeutics in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 23 increasing their positions, 11 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
24% less capital invested
Capital invested by funds: $546M → $415M (-$131M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
52
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$8.86M | |
| 2 | +$1.76M | |
| 3 | +$652K | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$588K |
| 5 |
Goldman Sachs
New York
|
+$500K |
Top Sellers
| 1 | -$3.45M | |
| 2 | -$1.73M | |
| 3 | -$1.33M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$735K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$186K |